Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simion I Chiosea

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Scientific Reports|May 17, 2020
Molecular Profile of Locally Aggressive Well Differentiated Thyroid CancersLeila J Mady, Michael C Grimes, Nayel I Khan, et al.
BMC Cancer|December 18, 2013
PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinomaSimion I Chiosea, Jennifer R Grandis, Vivian W Y Lui, et al.
Endocrine-Related Cancer|April 1, 2021
Molecular alterations in Hürthle cell nodules and preoperative cancer riskWilliam R Doerfler, Alyaksandr V Nikitski, Elena M Morariu, et al.
Neoplasia (New York, N.Y.)|March 27, 2015
JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growthMalabika Sen, Netanya I Pollock, John Black, et al.
The American Journal of Surgical Pathology|April 15, 2015
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expressionLindsay Williams, Lester D R Thompson, Raja R Seethala, et al.
The American Journal of Surgical Pathology|February 15, 2018
Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary GlandIlan Weinreb, Justin A Bishop, Simion I Chiosea, et al.
BMC Cancer|November 14, 2018
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinomaLiyong Zhang, Zhihong Li, Yehai Liu, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Oral Oncology|October 28, 2017
Improving margin revision: Characterization of tumor bed margins in early oral tongue cancerArpan V Prabhu, Charles D Sturgis, Chi Lai, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Scientific Reports|May 17, 2020
Molecular Profile of Locally Aggressive Well Differentiated Thyroid CancersLeila J Mady, Michael C Grimes, Nayel I Khan, et al.
BMC Cancer|December 18, 2013
PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinomaSimion I Chiosea, Jennifer R Grandis, Vivian W Y Lui, et al.
Endocrine-Related Cancer|April 1, 2021
Molecular alterations in Hürthle cell nodules and preoperative cancer riskWilliam R Doerfler, Alyaksandr V Nikitski, Elena M Morariu, et al.
Neoplasia (New York, N.Y.)|March 27, 2015
JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growthMalabika Sen, Netanya I Pollock, John Black, et al.
The American Journal of Surgical Pathology|April 15, 2015
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expressionLindsay Williams, Lester D R Thompson, Raja R Seethala, et al.
The American Journal of Surgical Pathology|February 15, 2018
Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary GlandIlan Weinreb, Justin A Bishop, Simion I Chiosea, et al.
BMC Cancer|November 14, 2018
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinomaLiyong Zhang, Zhihong Li, Yehai Liu, et al.
Cancer Cytopathology|August 19, 2014
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristicsLisa A Radkay, Simion I Chiosea, Raja R Seethala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2025
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P Zandberg, Lazar Vujanovic, David A Clump, et al.
Oral Oncology|October 28, 2017
Improving margin revision: Characterization of tumor bed margins in early oral tongue cancerArpan V Prabhu, Charles D Sturgis, Chi Lai, et al.
Pageof 10